Hospital-based services for cancer patients with children under the age of 18 should carefully address patients' fears of psychiatric stigmatization. Furthermore, they should include modules for acute crisis intervention. Implications for future implementation activities in this field are discussed.
Children having a parent who suffers from a serious somatic disease are at increased risk for mental health problems. Mainly due to the high prevalence of breast cancer diseases children of mothers with cancer are the most studied subgroup of this risk population. In this review the sequelae of a cancer diagnosis on a patient's female identity with respect to the maternal role are illuminated. Then, children's fears, conflicts and stressors that may be typically associated with maternal cancer are differentiated by age groups from a developmental perspective. In several controlled studies children of cancer patients had increased scores in symptom scales. If there are psychic symptoms, these are likely to manifest themselves as anxiety, depression, psychosomatic complaints or social withdrawal. Adolescent daughters of mothers having cancer had an especially increased risk to develop symptoms. The possible impact of a maternal cancer disease on a developing girl's puberty is discussed. In addition, a case vignette of a nine-year-old daughter of a breast cancer patient illustrates psychotherapeutic procedures in a brief intervention, the goal of which was to facilitate talking about fears between mother and daughter. Perspectives of family oriented mental health prevention in the context of gynaecological care are discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.